StonvexLoading…
StonvexStonvexStonvexCore line items from W's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.46B | $11.85B | $12.00B | $12.22B |
Operating Income | $17.00M | $-461.00M | $-813.00M | $-1.38B |
Net Income | $-313.00M | $-492.00M | $-738.00M | $-1.33B |
EPS (Diluted) | $-2.44 | $-4.01 | $-6.47 | $-12.54 |
Total Assets | $3.44B | $3.46B | $3.47B | $3.58B |
Total Liabilities | $6.22B | $6.21B | $6.18B | $6.13B |
Cash & Equivalents | $1.48B | $1.32B | $1.32B | $1.05B |
Free Cash Flow OCF − CapEx | $464.00M | $244.00M | $201.00M | $-860.00M |
Shares Outstanding | 128.00M | 123.00M | 114.00M | 106.00M |